Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Louisiana Off-Label Marketing Lawsuit

The State of Louisiana filed a lawsuit accusing GlaxoSmithKline of illegally promoting the drugs Paxil, Wellbutrin, Advair, Lamictal, Zofran, Imitrex, Lotronex, Flovent, and Valtrex for off-label uses from 1997 to 2010. The state alleged that GSK’s conduct (misrepresentations, false and/or fraudulent statements, misbranding, illegal marketing and promotion, and payment of illegal inducements to healthcare providers) caused false and fraudulent claims to be submitted to the Louisiana Medicaid and medical assistance programs, costing the state millions of dollars. In July 2013, Glaxo settled the lawsuit as part of a larger settlement with seven other states involving its Avandia diabetes drug (see GlaxoSmithKline instance, “Multistate Avandia Settlement (July 2013)”).

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Complaint
2/5/2013
Contractors Involved Penalty
Total
GlaxoSmithKline $45,000,000
Further Information Released
Louisiana AG Press Release (July 2013) 7/26/2013
Louisiana AG Press Release (Feb. 2013) 2/6/2013
Complaint 2/5/2013

See also:

Federal Contractor Misconduct Database